Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...